Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Debra Stephanie Barker
Age : 59
Public asset : 11,143 USD
Linked companies : Arix Bioscience plc - BerGenBio ASA - Destiny Pharma plc
Summary 
Debra Stephanie Barker is on the board of CureVac SE and 4 other companies. Dr. Barker previously occupied the position of Chief Medical & Development Officer at Spexis Ltd. and Global Head-Medical Affairs at Novartis AG.

Dr. Barker received a doctorate from Queens' College Cambridge and a graduate degree from King's College London.


Current positions of Debra Stephanie Barker 
NameTitle Since
Arix Bioscience plc
(Investment Management & Fund Operators)
Senior Independent Non-Executive Director 2022
BerGenBio ASA
(Biotechnology & Medical Research)
Non-Executive Director 2019
Destiny Pharma plc
(Biotechnology & Medical Research)
Independent Non-Executive Director 2020
CureVac SE Non-Executive Director -
Hutman Diagnostics AG Director -


Debra Stephanie Barker: Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/26LVMH's Arnault brushes off succession question
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
02/02Billionaire Cohen builds stake in Nordstrom, urges board shakeup
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
02/01Sony Group CFO Totoki to succeed Yoshida as president - Nikkei
RE
01/31Italy considers replacements for Starace as Enel CEO, sources say
RE
02/01Zuckerberg vows 'Year of Efficiency', Meta shares soar
RE
More news


© 2023 People and Ownership :   
Debra Stephanie Barker : Connections